Dr. Jones is a Research Analyst for Emerald Advisers, focusing on Technology. He joined the firm in the summer of 2013 after a postdoctoral fellowship in melanoma research and nanotechnology at the Penn State College of Medicine. Dr. Jones received his PhD in Pharmacology in the spring of 2012 from the Pennsylvania State University, Hershey Medical Center. He has authored papers in the fields of pharmacogenetics, cancer research, nanotechnology, and drug metablism. He received his MBA from the Pennsylvania State University in 2009, where he was inducted into the Beta Gamma Sigma National Business Honor Society. Dr. Jones received his BS degree in Biochemistry and Molecular Biology from Penn State University in 2006.